Jacobio Completes First Dose of IIa Clinical Trial of JAB-21822 on KRAS G12C and STK11 Co-mutation in China
BEIJING, Sept. 1, 2022 /PRNewswire/ -- JacobioPharma (1167.HK) announced that the company has dosed the first non-small cell lung cancer (NSCLC) patient with KRAS G12C and STK11 co-mutation in the Phase IIa trial of KRAS G12C inhibitor JAB-21822 in China. JAB-21822 is a KRAS G12C inhibitor independently developed by Jacobio utilizing the...
BGI-led Research Builds the World’s First Spatiotemporal Map of Brain Regeneration
HANGZHOU, China, Sept. 2, 2022 /PRNewswire/ --A multi-institute research team led by BGI-Research has used BGI Stereo-seq technology to construct the world first spatiotemporal cellular atlas of the axolotl (Ambystoma mexicanum) brain development and regeneration, revealing how a brain injury can heal itself. The study was published as the cover story in the latest issue of Science. The research...
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022
Non-clinical studies explored the potent anti-fibrotic and anti-inflammatory efficacy of BBT-301 and BBT-209 for IPF treatment Company enhances its strategic focus on fibrotic diseases inclusive of IPF with 1 clinical asset and 2 non-clinical assets BOSTON and SEONGNAM, South Korea, Sept. 2, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused on developing...
Pxierra is launching world’s first non-contact heart rate & breathe rate measurement AI baby monitor
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Pxierra is excited to announce the launch of its innovative AI Baby monitor. This new device is designed to provide non-contact heart rate and breathing rate measurement, making it easier and more convenient for parents to keep track of their newborns' vital signs. Pxierra is committed to providing parents with the latest...
Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence
HANGZHOU, China, Sept. 1, 2022 /PRNewswire/ -- On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its interim results for the six months ended June 30, 2022. Under repeated COVID-19 outbreaks, Venus Medtech intensified its focus on overseas...
Global Wellness Leader, iHerb Celebrates Its 26th Anniversary of Making Health & Wellness Products Easy and Affordable
The world's largest eCommerce platform, dedicated to vitamins, minerals, and supplements marks another year of continued expansion with special promotions PASADENA, Calif., Sept. 1, 2022 /PRNewswire/ -- iHerb, the destination for a curated selection of the world's best health and wellness products, is proud to commemorate its 26th anniversary. Founded in 1996...
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management
SHANGHAI, Sept 1, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today announced its newly added business section of oncology and other major disease management which is a part of its development strategy to...
Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
EAST RUTHERFORD, NJ, Sept. 1, 2022 /PRNewswire/ -- Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and...
Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
LUGANO, Switzerland, Sept. 1, 2022 /PRNewswire/ -- Helsinn Group ("Helsinn"), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and Juniper Biologics Pte Ltd, a science-led healthcare company focused on researching, developing and commercializing novel therapies, announced today the signing of an exclusive distribution license and supply agreement to...
Top healthcare executive sets up fundraising platform matching healthcare startups to medical investors
Chris Lee aims to transform healthcare fundraising through VentureBlick's fundraising platform and professional community SINGAPORE, Sept. 1, 2022 /PRNewswire/ -- Chris Lee, one of the most experienced healthcare executives having held senior positions including president of Medtronic Asia Pacific and head of Bayer Healthcare Asia Pacific, today announced his new role as...
